Cell-to-cell junction structures play a key role in cell growth rate control and cell polarization. In endothelial cells (EC), these structures are also involved in regulation of vascular permeability and leukocyte extravasation. To identify novel components in EC intercellular junctions, mAbs against these cells were produced and selected using a morphological screening by immunofluorescence microscopy. Two novel mAbs, LIA1/1 and VJ1/16, specifically recognized a 25-kD protein that was selectively localized at cell–cell junctions of EC, both in the primary formation of cell monolayers and when EC reorganized in the process of wound healing. This antigen corresponded to the recently cloned platelet-endothelial tetraspan antigen CD151/PETA-3 (platelet-endothelial tetraspan antigen-3), and was consistently detected at EC cell–cell contact sites. In addition to CD151/PETA-3, two other members of the tetraspan superfamily, CD9 and CD81/ TAPA-1 (target of antiproliferative antibody-1), localized at endothelial cell-to-cell junctions. Biochemical analysis demonstrated molecular associations among tetraspan molecules themselves and those of CD151/ PETA-3 and CD9 with α3β1 integrin. Interestingly, mAbs directed to both CD151/PETA-3 and CD81/ TAPA-1 as well as mAb specific for α3 integrin, were able to inhibit the migration of ECs in the process of wound healing. The engagement of CD151/PETA-3 and CD81/TAPA-1 inhibited the movement of individual ECs, as determined by quantitative time-lapse video microscopy studies. Furthermore, mAbs against the CD151/PETA-3 molecule diminished the rate of EC invasion into collagen gels. In addition, these mAbs were able to increase the adhesion of EC to extracellular matrix proteins. Together these results indicate that CD81/TAPA-1 and CD151/PETA-3 tetraspan molecules are components of the endothelial lateral junctions implicated in the regulation of cell motility, either directly or by modulation of the function of the associated integrin heterodimers.
Skip Nav Destination
Article navigation
4 May 1998
Article|
May 04 1998
Regulation of Endothelial Cell Motility by Complexes of Tetraspan Molecules CD81/TAPA-1 and CD151/PETA-3 with α3β1 Integrin Localized at Endothelial Lateral Junctions
María Yáñez-Mó,
María Yáñez-Mó
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Search for other works by this author on:
Arántzazu Alfranca,
Arántzazu Alfranca
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Search for other works by this author on:
Carlos Cabañas,
Carlos Cabañas
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Search for other works by this author on:
Mónica Marazuela,
Mónica Marazuela
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Search for other works by this author on:
Reyes Tejedor,
Reyes Tejedor
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Search for other works by this author on:
M. Angeles Ursa,
M. Angeles Ursa
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Search for other works by this author on:
Leonie K. Ashman,
Leonie K. Ashman
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Search for other works by this author on:
Manuel O. de Landázuri,
Manuel O. de Landázuri
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Search for other works by this author on:
Francisco Sánchez-Madrid
Francisco Sánchez-Madrid
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Search for other works by this author on:
María Yáñez-Mó
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Arántzazu Alfranca
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Carlos Cabañas
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Mónica Marazuela
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Reyes Tejedor
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
M. Angeles Ursa
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Leonie K. Ashman
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Manuel O. de Landázuri
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Francisco Sánchez-Madrid
*Servicio de Inmunología and ‡Servicio de Endocrinología, Hospital de la Princesa, Universidad Autónoma de Madrid; §Departamento de Bioquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain; and ‖Division of Haematology, Institute of Medical and Veterinary Science, University of Adelaide, SA 5000, Australia
Address all correspondence to F. Sánchez-Madrid, Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, 28006 Madrid, Spain. Tel.: 34-1-4023347. Fax: 34-1-3092496. E-mail: fsmadrid/ [email protected]
Received:
June 19 1997
Revision Received:
February 03 1998
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1998
J Cell Biol (1998) 141 (3): 791–804.
Article history
Received:
June 19 1997
Revision Received:
February 03 1998
Citation
María Yáñez-Mó, Arántzazu Alfranca, Carlos Cabañas, Mónica Marazuela, Reyes Tejedor, M. Angeles Ursa, Leonie K. Ashman, Manuel O. de Landázuri, Francisco Sánchez-Madrid; Regulation of Endothelial Cell Motility by Complexes of Tetraspan Molecules CD81/TAPA-1 and CD151/PETA-3 with α3β1 Integrin Localized at Endothelial Lateral Junctions . J Cell Biol 4 May 1998; 141 (3): 791–804. doi: https://doi.org/10.1083/jcb.141.3.791
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement